5月28日中欧医疗创新股票C净值下跌1.30%，近1个月累计上涨4.79%

Group 1 - The core point of the article highlights the performance of the China Europe Medical Innovation Stock C fund, which has a latest net value of 1.2024 yuan, reflecting a decrease of 1.30% [1] - The fund's performance over the past month shows a return of 4.79%, ranking 69 out of 801 in its category; over the past six months, it has achieved a return of 17.61%, ranking 33 out of 776; and since the beginning of the year, it has returned 21.17%, ranking 27 out of 785 [1] - The top ten holdings of the fund account for a total of 75.62%, with significant positions in companies such as WuXi AppTec (10.35%), Kelun-Biotech (10.15%), WuXi Biologics (9.82%), and others [1] Group 2 - The China Europe Medical Innovation Stock C fund was established on February 28, 2019, and as of March 31, 2025, it has a total scale of 3.524 billion yuan [1] - The fund is managed by Guo Lan, who has extensive experience in the investment management field, having previously worked at Guotai Junan Securities and Minsheng Zhiyin Fund Management [2]